- Filter by subject
- All results (205)
- Risk insights (145)
- Whitepapers & studies (16)
- Emerging risks (117)
- Emerging markets (88)
- Interviews & profiles (104)
- Business continuity (8)
- Nat Cat risks (15)
- Risk insights - Marine (11)
- Risk insights - Property (12)
- Fire risk (6)
- Flood risk (5)
- Environmental risks (10)
- Market Commentaries (6)
- Project risks (10)
- Green issues (8)
- Products (9)
Expert Risk Articles
For knowledge sharing worldwide, features on a variety of risk topics in both the AGCS in-house media and external publications.
Over-exposed - vineyard volatility amid a changing climate01 August 2017
Climate disruptions are increasing in volatility throughout the world. Among one of the hardest hit is agribusiness – specifically wineries – which depend on stable soils and climatological consistency.
Condition-based maintenance and cargo weighing regulations21 March 2016
Ship maintenance has traditionally been accomplished on a set interval of planned repair. Recently, however, a move to replace this method with condition-based maintenance strategies has enjoyed a rising interest.
Farm & Ranch Q&A22 February 2016
Atul Kulkarni, Global Head of Farm & Ranch at AGCS, talks about the impact of socioeconomic issues on traditional agribusiness operations and the shifting farming trends that promise to drastically alter the face of the market.
Entertainment Claims trends09 December 2015
The two most significant business interruption losses are due to a cast member/performer being unable to perform and extra expenses related to other circumstances preventing production, such as property damage.
Property & Engineering Claims trends09 December 2015
The shift of manufacturing to China and South East Asia, increased interdependencies, just-in-time production and diminishing stock are resulting in larger BI and contingent BI claims.
Case study: Business interruption at UCB’s Farchim facility09 December 2015
When an explosion inside the UCB plant in Switzerland completely destroyed a building and interrupted its manufacturing process, the global biopharma manufacturer was left facing a significant loss in income.